| Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer | Cellular and molecular life sciences |  | | 2023 | 126 | 345 |
|
| CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells | Science advances | | | 2023 | 94 | 470 |
|
| Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma | Journal of experimental & clinical cancer research | | | 2023 | 182 | 96 |
|
| Hsf1 and the molecular chaperone Hsp90 support a ‘rewiring stress response’ leading to an adaptive cell size increase in chronic stress | eLife | | | 2023 | 103 | 234 |
|
| Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer | Cancers | | | 2022 | 217 | 416 |
|
| Genetic and multidrug combinatorial screens unravel new mechanistic clues and optimised therapeutics for estrogen receptor alpha-mediated breast cancer | | | | 2022 | 433 | 210 |
|
| Translational reprogramming in response to accumulating stressors ensures critical threshold levels of Hsp90 for mammalian life | Nature communications | | | 2022 | 325 | 510 |
|
